Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kai Conrad Cecil Johnson"'
Autor:
Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, Dionisia Quiroga, Mahmoud Kassem, Michael Grimm, Abdul Miah, Craig Vargo, Michael Berger, Preeti Sudheendra, Ashley Pariser, Margaret E. Gatti-Mays, Nicole Williams, Daniel Stover, Sagar Sardesai, Robert Wesolowski, Bhuvaneswari Ramaswamy, Gary Tozbikian, Patrick M. Schnell, Mathew A. Cherian
Publikováno v:
Oncology and Therapy, Vol 11, Iss 3, Pp 361-374 (2023)
Abstract Introduction The immunomodulatory impact of corticosteroids and concurrent chemotherapy is poorly understood within triple-negative breast cancer (TNBC). On a biochemical level, steroids have been linked to the signaling of chemotherapy-resi
Externí odkaz:
https://doaj.org/article/951fd11c96b2499b9c3ae9275fe18e77
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-37 (2022)
Abstract Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death-ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable treatment responses which have revolutionized oncology. However, desp
Externí odkaz:
https://doaj.org/article/f2303e5250bb4f6f8b35ba625b99c539
Autor:
Kai Conrad Cecil Johnson, Ai Ni, Michael Grimm, Sagar D. Sardesai, Daniel G. Stover, Mathew Amprayil Cherian, Margaret Elena Gatti-Mays, Ashley Pariser, Preeti Khetarpal Sudheendra, Nicole Olivia Williams, Jeffrey Bryan VanDeusen, Bhuvaneswari Ramaswamy, Robert Wesolowski
Publikováno v:
Journal of Clinical Oncology. 40:532-532
532 Background: Limited compelling prospective and retrospective data regarding the added benefit of anti-HER2 therapy in the management of small, node-negative HER2-positive breast cancer (HER2+BC) exists, in part due to differences in outcome repor